vs
Axogen, Inc.（AXGN）与RE/MAX Holdings, Inc.（RMAX）财务数据对比。点击上方公司名可切换其他公司
RE/MAX Holdings, Inc.的季度营收约是Axogen, Inc.的1.2倍（$71.1M vs $61.5M），RE/MAX Holdings, Inc.净利率更高（2.0% vs -31.9%，领先33.9%），Axogen, Inc.同比增速更快（26.6% vs -1.8%），RE/MAX Holdings, Inc.自由现金流更多（$33.5M vs $-1.4M），过去两年Axogen, Inc.的营收复合增速更高（13.3% vs -4.7%）
Axogen总部位于美国佛罗里达州阿拉楚阿，是外科解决方案提供商，专注开发周围神经损伤修复相关产品，涵盖人体组织移植物、神经连接器、软组织膜等，旗下AVANCE细胞移植技术可模拟人体神经结构，临床数据显示其产品帮助87%的周围神经损伤患者实现感觉与运动功能恢复，2013年完成1800万美元首次公开募股。
RE/MAX是全球知名的房地产特许经营机构，业务遍布全球一百多个国家和地区，旗下拥有数千家门店，总计超过十万名房产经纪人，在国际房产中介领域拥有极高的品牌知名度与市场影响力。
AXGN vs RMAX — 直观对比
营收规模更大
RMAX
是对方的1.2倍
$61.5M
营收增速更快
AXGN
高出28.4%
-1.8%
净利率更高
RMAX
高出33.9%
-31.9%
自由现金流更多
RMAX
多$34.9M
$-1.4M
两年增速更快
AXGN
近两年复合增速
-4.7%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $61.5M | $71.1M |
| 净利润 | $-19.6M | $1.4M |
| 毛利率 | 75.2% | — |
| 营业利润率 | 20.2% | 13.1% |
| 净利率 | -31.9% | 2.0% |
| 营收同比 | 26.6% | -1.8% |
| 净利润同比 | -410.8% | -75.2% |
| 每股收益（稀释后） | $-0.38 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXGNRMAX
| Q1 26 | $61.5M | — | ||
| Q4 25 | $59.9M | $71.1M | ||
| Q3 25 | $60.1M | $73.2M | ||
| Q2 25 | $56.7M | $72.8M | ||
| Q1 25 | $48.6M | $74.5M | ||
| Q4 24 | $49.4M | $72.5M | ||
| Q3 24 | $48.6M | $78.5M | ||
| Q2 24 | $47.9M | $78.5M |
净利润AXGNRMAX
| Q1 26 | $-19.6M | — | ||
| Q4 25 | $-13.2M | $1.4M | ||
| Q3 25 | $708.0K | $4.0M | ||
| Q2 25 | $579.0K | $4.7M | ||
| Q1 25 | $-3.8M | $-2.0M | ||
| Q4 24 | $450.0K | $5.8M | ||
| Q3 24 | $-1.9M | $966.0K | ||
| Q2 24 | $-1.9M | $3.7M |
毛利率AXGNRMAX
| Q1 26 | 75.2% | — | ||
| Q4 25 | 74.1% | — | ||
| Q3 25 | 76.6% | — | ||
| Q2 25 | 74.2% | — | ||
| Q1 25 | 71.9% | — | ||
| Q4 24 | 76.1% | — | ||
| Q3 24 | 74.9% | — | ||
| Q2 24 | 73.8% | — |
营业利润率AXGNRMAX
| Q1 26 | 20.2% | — | ||
| Q4 25 | -16.3% | 13.1% | ||
| Q3 25 | 3.2% | 25.0% | ||
| Q2 25 | 3.0% | 19.3% | ||
| Q1 25 | -3.4% | 7.2% | ||
| Q4 24 | 4.1% | 5.9% | ||
| Q3 24 | -0.6% | 19.4% | ||
| Q2 24 | -0.9% | 20.6% |
净利率AXGNRMAX
| Q1 26 | -31.9% | — | ||
| Q4 25 | -22.0% | 2.0% | ||
| Q3 25 | 1.2% | 5.4% | ||
| Q2 25 | 1.0% | 6.4% | ||
| Q1 25 | -7.9% | -2.6% | ||
| Q4 24 | 0.9% | 8.0% | ||
| Q3 24 | -3.8% | 1.2% | ||
| Q2 24 | -4.0% | 4.7% |
每股收益（稀释后）AXGNRMAX
| Q1 26 | $-0.38 | — | ||
| Q4 25 | $-0.28 | — | ||
| Q3 25 | $0.01 | — | ||
| Q2 25 | $0.01 | — | ||
| Q1 25 | $-0.08 | — | ||
| Q4 24 | $-0.00 | — | ||
| Q3 24 | $-0.04 | — | ||
| Q2 24 | $-0.04 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $82.7M | $118.7M |
| 总债务越低越好 | — | $432.2M |
| 股东权益账面价值 | $244.8M | $452.4M |
| 总资产 | $289.5M | $582.5M |
| 负债/权益比越低杠杆越低 | — | 0.96× |
8季度趋势，按日历期对齐
现金及短期投资AXGNRMAX
| Q1 26 | $82.7M | — | ||
| Q4 25 | $41.5M | $118.7M | ||
| Q3 25 | $35.8M | $107.5M | ||
| Q2 25 | $29.9M | $94.3M | ||
| Q1 25 | $22.1M | $89.1M | ||
| Q4 24 | $33.5M | $96.6M | ||
| Q3 24 | $24.5M | $83.8M | ||
| Q2 24 | $21.1M | $66.1M |
总债务AXGNRMAX
| Q1 26 | — | — | ||
| Q4 25 | $48.4M | $432.2M | ||
| Q3 25 | $48.2M | $433.3M | ||
| Q2 25 | $47.9M | $434.4M | ||
| Q1 25 | $47.7M | $435.3M | ||
| Q4 24 | $47.5M | $436.2M | ||
| Q3 24 | $47.3M | $437.2M | ||
| Q2 24 | $47.0M | $438.1M |
股东权益AXGNRMAX
| Q1 26 | $244.8M | — | ||
| Q4 25 | $128.8M | $452.4M | ||
| Q3 25 | $120.8M | $448.1M | ||
| Q2 25 | $112.3M | $442.4M | ||
| Q1 25 | $105.4M | $433.5M | ||
| Q4 24 | $103.9M | $429.5M | ||
| Q3 24 | $99.4M | $423.1M | ||
| Q2 24 | $95.7M | $418.4M |
总资产AXGNRMAX
| Q1 26 | $289.5M | — | ||
| Q4 25 | $221.7M | $582.5M | ||
| Q3 25 | $216.4M | $582.2M | ||
| Q2 25 | $205.5M | $574.8M | ||
| Q1 25 | $196.2M | $571.4M | ||
| Q4 24 | $203.7M | $581.6M | ||
| Q3 24 | $192.0M | $578.6M | ||
| Q2 24 | $188.9M | $571.4M |
负债/权益比AXGNRMAX
| Q1 26 | — | — | ||
| Q4 25 | 0.38× | 0.96× | ||
| Q3 25 | 0.40× | 0.97× | ||
| Q2 25 | 0.43× | 0.98× | ||
| Q1 25 | 0.45× | 1.00× | ||
| Q4 24 | 0.46× | 1.02× | ||
| Q3 24 | 0.48× | 1.03× | ||
| Q2 24 | 0.49× | 1.05× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $40.9M |
| 自由现金流经营现金流 - 资本支出 | $-1.4M | $33.5M |
| 自由现金流率自由现金流/营收 | -2.3% | 47.1% |
| 资本支出强度资本支出/营收 | — | 10.4% |
| 现金转化率经营现金流/净利润 | — | 28.39× |
| 过去12个月自由现金流最近4个季度 | $9.1M | $56.8M |
8季度趋势，按日历期对齐
经营现金流AXGNRMAX
| Q1 26 | — | — | ||
| Q4 25 | $3.0M | $40.9M | ||
| Q3 25 | $3.2M | $17.7M | ||
| Q2 25 | $7.7M | $4.6M | ||
| Q1 25 | $-13.2M | $5.7M | ||
| Q4 24 | $8.7M | $59.7M | ||
| Q3 24 | $3.9M | $17.6M | ||
| Q2 24 | $4.2M | $15.9M |
自由现金流AXGNRMAX
| Q1 26 | $-1.4M | — | ||
| Q4 25 | $1.8M | $33.5M | ||
| Q3 25 | $1.7M | $16.4M | ||
| Q2 25 | $7.0M | $2.9M | ||
| Q1 25 | $-13.4M | $4.0M | ||
| Q4 24 | $8.1M | $53.0M | ||
| Q3 24 | $3.3M | $16.3M | ||
| Q2 24 | $3.3M | $14.0M |
自由现金流率AXGNRMAX
| Q1 26 | -2.3% | — | ||
| Q4 25 | 3.0% | 47.1% | ||
| Q3 25 | 2.8% | 22.4% | ||
| Q2 25 | 12.4% | 4.0% | ||
| Q1 25 | -27.7% | 5.3% | ||
| Q4 24 | 16.3% | 73.2% | ||
| Q3 24 | 6.8% | 20.8% | ||
| Q2 24 | 6.8% | 17.8% |
资本支出强度AXGNRMAX
| Q1 26 | — | — | ||
| Q4 25 | 2.1% | 10.4% | ||
| Q3 25 | 2.5% | 1.8% | ||
| Q2 25 | 1.3% | 2.2% | ||
| Q1 25 | 0.5% | 2.3% | ||
| Q4 24 | 1.4% | 9.1% | ||
| Q3 24 | 1.2% | 1.7% | ||
| Q2 24 | 1.9% | 2.4% |
现金转化率AXGNRMAX
| Q1 26 | — | — | ||
| Q4 25 | — | 28.39× | ||
| Q3 25 | 4.55× | 4.45× | ||
| Q2 25 | 13.35× | 0.97× | ||
| Q1 25 | — | — | ||
| Q4 24 | 19.41× | 10.28× | ||
| Q3 24 | — | 18.22× | ||
| Q2 24 | — | 4.29× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AXGN
暂无分部数据
RMAX
| Franchising Segment | $50.1M | 70% |
| Broker Fees | $13.9M | 20% |
| Annual Dues | $7.4M | 10% |
